• Gefitinib (ZD1839) in Patient-Derived Tumor Assembloid Resea

  2026-07-29

  Gefitinib (ZD1839) unlocks nuanced interrogation of EGFR signaling and resistance mechanisms in complex patient-derived assembloid models. This guide details optimized experimental workflows, troubleshooting strategies, and actionable protocol parameters to maximize translational impact in cancer research.

• Mavorixafor hydrochloride (SKU A3174): Reliable CXCR4 Antago

  2026-07-29

  This article provides an evidence-based, scenario-driven guide for leveraging Mavorixafor hydrochloride (SKU A3174) in cell viability, proliferation, and CXCR4 signaling assays. Drawing from phase 3 clinical trial data and hands-on laboratory challenges, we highlight the compound’s data-backed performance, solubility, and workflow compatibility. Researchers will find practical guidance for optimizing protocols and selecting reliable suppliers such as APExBIO.

• Multianimal MRI Streamlines Tumor Assessment in Pancreatic M

  2026-07-28

  Kempinska et al. introduce a multianimal MRI protocol that enables high-resolution, parallel imaging of pancreatic tumors in genetically engineered mouse models. This methodological advance significantly improves the efficiency and cost-effectiveness of preclinical studies, including the evaluation of gemcitabine-based therapies in pancreatic ductal adenocarcinoma.

• SCH772984 HCl: Reliable ERK1/2 Inhibition for Cell Assays

  2026-07-28

  This article provides evidence-based guidance on using SCH772984 HCl (SKU B5866) for reproducible inhibition of ERK1/2 in cell viability and proliferation assays. Drawing on quantitative data and recent literature, we address practical challenges faced by biomedical researchers and demonstrate why this MAPK pathway inhibitor from APExBIO is a reliable choice for studies involving BRAF- and RAS-mutant tumor models.

• Multiplexed ACE2 Libraries Reveal SARS-CoV-2 Variant Adaptat

  2026-07-27

  Shukla et al. (2024) introduced a high-throughput barcoded infection assay to reveal how SARS-CoV-2 spike protein variants shift receptor compatibility across diverse ACE2 orthologs and mutants. This work uncovers complex mechanisms of viral adaptation and expands our understanding of cross-species transmission potential.

• L-Phenylephrine and Sex-Specific Adrenergic Signaling Insigh

  2026-07-27

  Explore how L-Phenylephrine, a selective adrenergic α1A receptor agonist, drives nuanced research into sex-specific cardiovascular signaling. This article uniquely bridges molecular pharmacology with translational assay design, offering perspectives not found in standard workflows.

• RRP Extracts Restore Hepatic Lipid Metabolism in Ischemia-Re

  2026-07-26

  This study demonstrates that Radix Rehmanniae Praeparata (RRP) extracts ameliorate hepatic ischemia-reperfusion injury (HIRI) in mice by restoring lipid metabolism. Mechanistically, RRP acts via AMPK activation, SREBP2 inhibition, and LXRα-driven cholesterol efflux, highlighting new intervention points for post-surgical liver injury.

• BI 2536 and PLK1: Redefining Mitotic Checkpoint Regulation i

  2026-07-25

  Explore how BI 2536, a potent PLK1 inhibitor, uniquely illuminates the regulation of mitotic checkpoint disassembly and G2/M cell cycle arrest in cancer models. Gain practical, mechanistic insight that advances both experimental design and translational oncology.

• Cardiogreen (Indocyanine Green): Applied Workflows & Innovat

  2026-07-24

  Cardiogreen (Indocyanine Green) stands out for its dual role in vascular diagnostics and advanced photodynamic therapy. This guide translates cutting-edge research into robust protocols, troubleshooting tactics, and actionable insights for reproducible results across cardiovascular, hepatic, and oncology applications.

• D-N-Acetylgalactosamine: Technical Guidance for Brain Resear

  2026-07-24

  D-N-Acetylgalactosamine is a high-purity, water-soluble standard optimized for studying glycoprotein constituents and glycosylation pathways in neurological and biochemical research. It is not recommended for workflows requiring ethanol solubility or long-term solution storage. Researchers should follow strict protocol guidance to ensure reproducibility and data quality.

• HyperPFU™ High-Fidelity DNA Polymerase: Technical PCR Guidan

  2026-07-23

  HyperPFU™ high-fidelity DNA polymerase addresses the persistent challenges of accurate PCR amplification for long or GC-rich DNA templates, where standard enzymes often fail due to fidelity or processivity limits. It is ideal for workflows demanding high accuracy and blunt-ended PCR products, but should not be used for applications requiring 3'-A overhangs or sticky-end generation.

• Trifluoperazine 2HCl: A Strategic Lever in Translational Neu

  2026-07-23

  This thought-leadership article dissects the mechanistic and translational value of Trifluoperazine 2HCl as a dopamine D2 receptor inhibitor, emphasizing its cross-disciplinary potential in neuroscience, immunology, and oncology. By integrating evidence from recent metabolic and immune-oncology studies, the piece offers actionable guidance for researchers seeking robust, reproducible results in dopamine receptor signaling and neuropharmacology assays, while also highlighting strategic considerations for advancing from bench to bedside.

• AZD1480 as a JAK2 Inhibitor: Optimizing STAT3 Pathway Assays

  2026-07-22

  AZD1480, a potent JAK2 inhibitor from APExBIO, empowers researchers to dissect and target the JAK2/STAT3 axis in tumor biology—especially in the context of IDO1 inhibition-induced resistance. This guide delivers stepwise experimental workflows, troubleshooting strategies, and practical insights for maximizing reproducibility and translational relevance in cancer models.

• CBD Attenuates Orofacial Inflammatory Pain via Endocannabino

  2026-07-22

  The reference study demonstrates that cannabidiol (CBD) robustly alleviates both the sensory and affective components of orofacial inflammatory pain in mice by modulating endocannabinoid and serotonergic signaling. This multidimensional approach suggests translational potential for comprehensive pain management strategies, particularly in conditions where both pain and emotional comorbidities are clinically significant.

• High Viscosity Drives Chemoresistance via P-gp Upregulation

  2026-07-21

  This study demonstrates that elevated extracellular fluid viscosity in the tumor microenvironment triggers chemoresistance in cancer cells by upregulating P-glycoprotein (P-gp) through mechanosensitive signaling. The findings reveal a direct mechanobiological link between tumor physical properties and ABC transporter-mediated drug resistance, providing new directions for overcoming chemoresistance.

456 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page